Filing Details
- Accession Number:
- 0001127602-24-016791
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-05-29 17:10:56
- Reporting Period:
- 2024-03-08
- Accepted Time:
- 2024-05-29 17:10:56
- Original Submission Date:
- 2024-03-11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1543779 | Gunnar Michael Knell | C/O Charles River Laboratories 251 Ballardvale Street Wilmington MA 01887 | Csvp&Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-08 | 808 | $267.52 | 8,633 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-08 | 808 | $267.52 | 7,825 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2024-03-08 | 808 | $0.00 | 808 | $179.66 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 404 | 2021-05-29 | 2030-05-29 | No | 4 | M | Direct |
Billionaire Hedge Funds
